EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 60.52 Billion EUR | -0.06% |
| 2022 | 60.56 Billion EUR | 1.91% |
| 2021 | 59.42 Billion EUR | 13.59% |
| 2020 | 52.31 Billion EUR | -0.5% |
| 2019 | 52.58 Billion EUR | 13.65% |
| 2018 | 46.26 Billion EUR | 276.17% |
| 2017 | 12.3 Billion EUR | -6.56% |
| 2016 | 13.16 Billion EUR | 9.96% |
| 2015 | 11.97 Billion EUR | 10.96% |
| 2014 | 10.78 Billion EUR | 42.39% |
| 2013 | 7.57 Billion EUR | 9.7% |
| 2012 | 6.9 Billion EUR | 12.16% |
| 2011 | 6.15 Billion EUR | 18.13% |
| 2010 | 5.21 Billion EUR | 25.08% |
| 2009 | 4.16 Billion EUR | 2.47% |
| 2008 | 4.06 Billion EUR | 15.75% |
| 2007 | 3.51 Billion EUR | 12.49% |
| 2006 | 3.12 Billion EUR | 3.22% |
| 2005 | 3.02 Billion EUR | 17.1% |
| 2004 | 2.58 Billion EUR | 3.56% |
| 2003 | 2.49 Billion EUR | 15.64% |
| 2002 | 2.15 Billion EUR | 0.39% |
| 2001 | 2.14 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 61.49 Billion EUR | 1.6% |
| 2024 Q2 | 61.49 Billion EUR | 0.0% |
| 2023 Q2 | 60.22 Billion EUR | 0.0% |
| 2023 Q1 | 60.22 Billion EUR | -0.55% |
| 2023 Q4 | 60.52 Billion EUR | 0.0% |
| 2023 Q3 | 60.52 Billion EUR | 0.49% |
| 2023 FY | 60.52 Billion EUR | -0.06% |
| 2022 Q3 | 60.56 Billion EUR | -4.46% |
| 2022 Q4 | 60.56 Billion EUR | 0.0% |
| 2022 Q1 | 63.39 Billion EUR | 6.67% |
| 2022 FY | 60.56 Billion EUR | 1.91% |
| 2022 Q2 | 63.39 Billion EUR | 0.0% |
| 2021 FY | 59.42 Billion EUR | 13.59% |
| 2021 Q1 | 53.77 Billion EUR | 2.78% |
| 2021 Q4 | 59.42 Billion EUR | 0.02% |
| 2021 Q2 | 53.77 Billion EUR | 0.0% |
| 2021 Q3 | 59.41 Billion EUR | 10.49% |
| 2020 FY | 52.31 Billion EUR | -0.5% |
| 2020 Q3 | 52.31 Billion EUR | -3.21% |
| 2020 Q1 | 54.05 Billion EUR | 2.8% |
| 2020 Q4 | 52.31 Billion EUR | 0.0% |
| 2020 Q2 | 54.05 Billion EUR | 0.0% |
| 2019 Q1 | 48.03 Billion EUR | 3.82% |
| 2019 FY | 52.58 Billion EUR | 13.65% |
| 2019 Q3 | 52.58 Billion EUR | 9.46% |
| 2019 Q4 | 52.58 Billion EUR | 0.0% |
| 2019 Q2 | 48.03 Billion EUR | 0.0% |
| 2018 Q2 | 12.59 Billion EUR | 0.0% |
| 2018 FY | 46.26 Billion EUR | 276.17% |
| 2018 Q4 | 46.26 Billion EUR | -4.4% |
| 2018 Q3 | 48.39 Billion EUR | 284.2% |
| 2018 Q1 | 12.59 Billion EUR | 2.41% |
| 2017 Q4 | 12.3 Billion EUR | 22.22% |
| 2017 Q3 | 10.06 Billion EUR | -21.74% |
| 2017 Q2 | 12.86 Billion EUR | 0.0% |
| 2017 Q1 | 12.86 Billion EUR | -2.3% |
| 2017 FY | 12.3 Billion EUR | -6.56% |
| 2016 Q2 | 12.24 Billion EUR | 0.0% |
| 2016 FY | 13.16 Billion EUR | 9.96% |
| 2016 Q1 | 12.24 Billion EUR | 2.32% |
| 2016 Q3 | 13.16 Billion EUR | 7.46% |
| 2016 Q4 | 13.16 Billion EUR | 0.0% |
| 2015 Q3 | 11.97 Billion EUR | 2.9% |
| 2015 FY | 11.97 Billion EUR | 10.96% |
| 2015 Q2 | 11.63 Billion EUR | 0.0% |
| 2015 Q4 | 11.97 Billion EUR | 0.0% |
| 2015 Q1 | 11.63 Billion EUR | 7.83% |
| 2014 Q2 | 10.23 Billion EUR | 0.0% |
| 2014 FY | 10.78 Billion EUR | 42.39% |
| 2014 Q3 | 10.78 Billion EUR | 5.39% |
| 2014 Q4 | 10.78 Billion EUR | 0.0% |
| 2014 Q1 | 10.23 Billion EUR | 35.11% |
| 2013 Q1 | 7.13 Billion EUR | 3.26% |
| 2013 Q4 | 7.57 Billion EUR | 0.0% |
| 2013 Q3 | 7.57 Billion EUR | 6.23% |
| 2013 Q2 | 7.13 Billion EUR | 0.0% |
| 2013 FY | 7.57 Billion EUR | 9.7% |
| 2012 Q4 | 6.9 Billion EUR | 0.0% |
| 2012 Q2 | 6.75 Billion EUR | 0.0% |
| 2012 FY | 6.9 Billion EUR | 12.16% |
| 2011 FY | 6.15 Billion EUR | 18.13% |
| 2011 Q2 | 5.25 Billion EUR | 0.0% |
| 2011 Q4 | 6.15 Billion EUR | 0.0% |
| 2010 Q2 | 5.42 Billion EUR | 0.0% |
| 2010 FY | 5.21 Billion EUR | 25.08% |
| 2010 Q4 | 5.21 Billion EUR | 0.0% |
| 2009 Q4 | 4.16 Billion EUR | 0.0% |
| 2009 FY | 4.16 Billion EUR | 2.47% |
| 2008 FY | 4.06 Billion EUR | 15.75% |
| 2007 FY | 3.51 Billion EUR | 12.49% |
| 2006 FY | 3.12 Billion EUR | 3.22% |
| 2005 FY | 3.02 Billion EUR | 17.1% |
| 2004 FY | 2.58 Billion EUR | 3.56% |
| 2003 FY | 2.49 Billion EUR | 15.64% |
| 2002 FY | 2.15 Billion EUR | 0.39% |
| 2001 FY | 2.14 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -3292665.198% |
| Ansell Limited | 3.23 Billion USD | -1769.996% |
| Ansell Limited | 3.24 Billion USD | -1766.496% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -12277.181% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -20149918.977% |
| Psykey, Inc. | 1.72 Million USD | -3503686.124% |
| ConvaTec Group Plc | 3.7 Billion USD | -1532.027% |
| ConvaTec Group Plc | 3.71 Billion USD | -1529.722% |
| Encision Inc. | 3.81 Million USD | -1588131.713% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -9284263.25% |
| LifePoint, Inc. | 8.8 Million USD | -686945.353% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -379211.858% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -6762246.369% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -1102514.791% |
| Reflect Scientific, Inc. | 2.66 Million USD | -2267610.741% |
| SmileDirectClub, Inc. | 597.06 Million USD | -10036.786% |
| Sector 10, Inc. | 1000.00 USD | -6052299900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -1175.185% |
| SheerVision, Inc. | 837.56 Thousand USD | -7225966.037% |
| United Health Products, Inc. | 284.64 Thousand USD | -21262674.774% |
| Vasamed, Inc. | 1.6 Million USD | -3782013.092% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -27119219.989% |
| Yubo International Biotech Limited | 2.34 Million USD | -2576935.798% |